External collaborations Show filterHide filter All AllIndustrial partnersInternational alliances BEAM Alliance Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong Network… BioNTech In collaboration with BioNTech and the TRON Research Institute, the DZIF is researching RNA-based vaccines for selected virus… CARB-X CARB-X (Combating Antibiotic Resistant Biopharmaceutical Accelerator) is a funding organisation for projects in the field of… Coalition for Epidemic Preparedness Innovations (CEPI) The global community wants to be better prepared for serious infectious disease epidemics than before. For this purpose, the… Coris BioConcept The DZIF scientists from the Institute of Medical Microbiology at the University of Cologne have generated antibodies against… Global AMR R&D Hub The Global Antimicrobial Resistance Research and Development Hub, or Global AMR R&D Hub for short, is an initiative of… HYpharm GmbH HYpharm GmbH and a consortium funded by the DZIF are collaborating to manufacture and preclinically develop phage lytic… IDT Biologika Together with the company IDT Biologika, the DZIF is developing a vaccine against the MERS coronavirus in a consortium of… INCATE - Incubator for Antibacterial Therapies in Europe Multi-resistant bacteria are spreading worldwide. New antibiotics and strategies against deadly infectious diseases are… Juno Therapeutics Juno Therapeutics, formerly Stage Cell Therapeutics, is collaborating and exploitation partner of the research group led by… Pagination < previous Current page 1 Page 2 Page 1 Page 2 Next page ››
